Last reviewed · How we verify

NCT04499976

Isonicotinic Acid Hydrazide Pretreatment With Misoprostol Induction of Abortion in First-trimester Missed Miscarriage

Status unknown Phase 4 Last updated 5 August 2020
What this trial tests

Phase 4 trial testing Isonicotinic Acid in Abortion, Missed in 240 participants. Status unknown.

Timeline
1 September 2020
Primary endpoint
30 April 2021
30 June 2021

Quick facts

Lead sponsorAswan University Hospital
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment240
Start date1 September 2020
Primary completion30 April 2021
Estimated completion30 June 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Aswan University Hospital

Who can join

Adults 18 to 45, female only, with Abortion, Missed. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compares the success rate of Adjuvant isonicotinic acid hydrazide and misoprostol versus misoprostol alone for medical termination of first-trimester pregnancy among women with one or more previous cesarean deliveries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Abortion, Missed

Currently open trials in the same condition.

Other Aswan University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04499976.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing